or Try an Advanced Search...

    Bruton's Tyrosine Kinase Stocks List

    Symbol Grade Name % Change
    NRIX D Nurix Therapeutics, Inc. -1.43
    BGNE D BeiGene, Ltd. -2.08
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Cancer Lymphoma Biotechnology Enzymes Gilead Sciences IBD 50 Immune Disorders Life Sciences Monoclonal Antibodies Monoclonal Antibody Oncogene Oncogenes Protein Kinase Ras Subfamily Rp1 Small Molecule Therapies Treatment Of Cancer Tyrosine Kinase

    Related ETFs - A few ETFs which own one or more of the above listed Bruton's Tyrosine Kinase stocks.

    Symbol Grade Name Weight
    IDNA F iShares Genomics Immunology and Healthcare ETF 6.65
    KURE D KraneShares MSCI All China Health Care Index ETF 6.13
    CANC F Tema Oncology ETF 3.45
    ARKG F ARK Genomic Revolution Multi-Sector ETF 3.38
    FFTY A Innovator IBD 50 Fund ETF 2.79
    View all Bruton's Tyrosine Kinase ETFs...
    Compare ETFs
    Compare CANC to ARKG Compare IDNA to ARKG Compare KURE to CANC

        Bruton's Tyrosine Kinase Stocks Recent News

        Date Stock Title
        Nov 20 NRIX Nurix Therapeutics Receives PRIME Designation from the European Medicines Agency for NX-5948 for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia
        Nov 19 BGNE Labcorp CFO Glenn Eisenberg Announces Plans to Retire
        Nov 19 BGNE BeiGene Announces Settlement of Litigation Against Generic Filer of BRUKINSA
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Cancer Lymphoma Biotechnology Enzymes Gilead Sciences IBD 50 Immune Disorders Life Sciences Monoclonal Antibodies Monoclonal Antibody Oncogene Oncogenes Protein Kinase Ras Subfamily Rp1 Small Molecule Therapies Treatment Of Cancer Tyrosine Kinase
        Bruton's Tyrosine Kinase

        Bruton's Tyrosine Kinase (BTK) is an enzyme that is involved in the signaling pathways of B-cells, which are a type of white blood cell. BTK is essential for B-cell development and activation, and mutations in the BTK gene can lead to a variety of immunodeficiency disorders.

        Browse All Tags